NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India-Pakistan Trade Ban Enters Second Year with No End in Sight

One year after the Pahalgam terror attack on May 6-7, 2025, India's economic measures imposed in response remain firmly in place. The Attari-Wagah border, the sole land trade route between the two nations, continues to be shut, while Pakistani airspace remains closed to Indian airlines. The Indus Waters Treaty, a decades-old agreement governing water access, hangs in abeyance, with no signs of a resolution.

The impact on bilateral trade has been devastating. Prior to the ban, India-Pakistan trade had already declined sharply from $2.41 billion in 2018 to $1.2 billion by 2024. The last full pre-ban period saw India export $447.65 million to Pakistan, while Pakistan's exports to India stood at just $0.42 million.

Pre-Ban Trade (2024-2025)India Exports to PakistanPakistan Exports to India
2024$447.65 million$0.42 million
2025 (Jan-Mar)$208 million$0.12 million

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Despite the formal ban, some trade continues, albeit in a limited capacity. In July-September 2025, Pakistan imported $36.6 million from India, primarily pharmaceutical raw materials under humanitarian exemptions. Informal trade routed through third countries like the UAE and Singapore has been estimated at $10 billion, though enforcement efforts are in place to curb it.

The Attari-Wagah Integrated Check Post remains closed as of May 2026, disrupting Afghanistan's imports and severely impacting the local economy. Pakistan's airspace has been closed to all Indian carriers since April 24, 2025, with significant financial losses estimated at Rs 7,000 crore ($800 million) annually.

The Indus Waters Treaty, which has survived three India-Pakistan wars without interruption, remains in abeyance. India's Home Minister Amit Shah has stated that the treaty will never be restored, while Pakistan's President Asif Ali Zardari has expressed concerns over India's decision, which he believes undermines the treaty's spirit.

Pakistan's economy has been severely impacted, particularly in the pharmaceutical sector, which was heavily reliant on Indian imports. With the ban in place, Pakistan's pharma industry has been forced to seek alternative suppliers, resulting in significantly higher costs. The country's broader economic position provides little buffer, as it is in the midst of its 25th IMF bailout.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

As of May 2026, all measures remain in force, with no visible diplomatic pathway to resuming trade in sight. The India-Pakistan trade ban continues to exact a heavy toll on both economies, with no end to the impasse in sight.

Investor Takeaway

Investors should be cautious of the ongoing trade tensions between India and Pakistan.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.